Unipolare Depression Langfassung - Versorgungsleitlinien.de

629. Kallen BA, Otterblad OP. Maternal use of selective serotonin re-uptake inhibitors in early
pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol
2007;79(4):301-8.
630. Louik C, Lin AE, Werler MM, Hernandez-Diaz S, Mitchell AA. First-trimester use of selective
serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007;356(26):2675-
83.
631. Malm H, Klaukka T, Neuvonen PJ. Risks associated with selective serotonin reuptake
inhibitors in pregnancy. Obstet Gynecol 2005;106(6):1289-96.
632. Rahimi R, Nikfar S, Abdollahi M. Pregnancy outcomes following exposure to serotonin
reuptake inhibitors: a meta-analysis of clinical trials. Reprod Toxicol 2006;22(4):571-5.
633. Einarson TR, Einarson A. Newer antidepressants in pregnancy and rates of major
malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug
Saf 2005;14(12):823-7.
634. Einarson A, Pistelli A, DeSantis M, Malm H, Paulus WD, Panchaud A, Kennedy D, Einarson
TR, Koren G. Evaluation of the risk of congenital cardiovascular defects associated with use of
paroxetine during pregnancy. Am J Psychiatry 2008;165(6):749-52.
635. Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Berard A, Koren G.
Paroxetine and congenital malformations: meta-Analysis and consideration of potential
confounding factors. Clin Ther 2007;29(5):918-26.
636. O'Brien L, Einarson TR, Sarkar M, Einarson A, Koren G. Does paroxetine cause cardiac
malformations? J Obstet Gynaecol Can 2008;30(8):696-701.
637. Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL. Neonatal signs after
late in utero exposure to serotonin reuptake inhibitors: literature review and implications for
clinical applications. JAMA 2005;293(19):2372-83.
638. Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards R. Selective serotonin reuptake
inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet
2005;365(9458):482-7.
639. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell
AA. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of
the newborn. N Engl J Med 2006;354(6):579-87.
640. Lattimore KA, Donn SM, Kaciroti N, Kemper AR, Neal CR, Jr., Vazquez DM. Selective
serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and
newborn: a meta-analysis. J Perinatol 2005;25(9):595-604.
641. Way CM. Safety of newer antidepressants in pregnancy. Pharmacotherapy 2007;27(4):546-
52.
642. Hemels ME, Einarson A, Koren G, Lanctot KL, Einarson TR. Antidepressant use during
pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother
2005;39(5):803-9.
643. Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL, Wisner KL. Pooled
analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J
Psychiatry 2004;161(6):1066-78.
644. Viguera AC, Newport DJ, Ritchie J, Stowe Z, Whitfield T, Mogielnicki J, Baldessarini RJ,
Zurick A, Cohen LS. Lithium in breast milk and nursing infants: clinical implications. Am J
Psychiatry 2007;164(2):342-5.
645. Pons G, Rey E, Matheson I. Excretion of psychoactive drugs into breast milk. Pharmacokinetic
principles and recommendations. Clin Pharmacokinet 1994;27(4):270-89.
646. Schaefer C, Spielmann H, Vetter K. Arzneiverordnung in Schwangerschaft und Stillzeit. 7th
ed. München: Urban und Fischer; 2006.
647. Stoppe G, Doren M. Critical appraisal of effects of estrogen replacement therapy on
symptoms of depressed mood. Arch Womens Ment Health 2002;5(2):39-47.
648. Stoppe G, von Sydow K, Krasney N. Die Psyche in der Peri- und Postmenopause.
Reproduktionsmed 2000;16:253-60.
© 2009 233